{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:32:41Z","timestamp":1793309561334,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020953","name":"Taiwan Centers for Disease Control","doi-asserted-by":"publisher","award":["MOHW111-CDC-C-114-000104"],"award-info":[{"award-number":["MOHW111-CDC-C-114-000104"]}],"id":[{"id":"10.13039\/100020953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2113-M-002-010-MY3"],"award-info":[{"award-number":["NSTC 113-2113-M-002-010-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jpba.2026.117724","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:36:04Z","timestamp":1789054564000},"page":"117724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of dried blood spots relative to peripheral blood mononuclear cells for intracellular tenofovir-diphosphate and emtricitabine-triphosphate assessment using liquid chromatography-tandem mass spectrometry"],"prefix":"10.1016","volume":"283","author":[{"given":"Ya-Ting","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ning","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ching","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Ching","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-0360","authenticated-orcid":false,"given":"Ching-Hua","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117724_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114554","article-title":"HIV nucleoside reverse transcriptase inhibitors","volume":"240","author":"Amblard","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2026.117724_bib2","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2026.117724_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11904-019-00450-9","article-title":"Current and future PrEP medications and modalities: on-demand, injectables, and topicals","volume":"16","author":"Beymer","year":"2019","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.jpba.2026.117724_bib4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/jac\/dkz068","article-title":"Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide","volume":"74","author":"Cerrone","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2026.117724_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2015.11.009","article-title":"Tenofovir alafenamide: a novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus","volume":"125","author":"Ray","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2026.117724_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000613","article-title":"Virtual global transplant laboratory standard operating procedures for blood collection, pbmc isolation, and storage","volume":"2","author":"Higdon","year":"2016","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.jpba.2026.117724_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/7651_2014_99","article-title":"Peripheral blood mononuclear cells: isolation, freezing, thawing, and culture","volume":"1304","author":"Riedhammer","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2026.117724_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/17512433.2023.2224562","article-title":"Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities","volume":"16","author":"M\u00fcller","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2026.117724_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s13318-023-00846-4","article-title":"Dried Blood Spots-A Platform for Therapeutic Drug Monitoring (TDM) and Drug\/Disease Response Monitoring (DRM)","volume":"48","author":"Zailani","year":"2023","journal-title":"Eur. J. Drug. Metab. Pharmacokinet."},{"key":"10.1016\/j.jpba.2026.117724_bib10","first-page":"e720","article-title":"Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC\/FTC\/TAF and Rifampicin","author":"Osuala","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2026.117724_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","article-title":"Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots","volume":"122","author":"Zheng","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117724_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/cid\/ciab1068","article-title":"Use of tenofovir diphosphate levels to predict viremia during the postpartum period in women living with human immunodeficiency virus (HIV): a nested case-control study","volume":"75","author":"Odayar","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2026.117724_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad080","article-title":"Effectiveness and safety of bictegravir\/emtricitabine\/tenofovir alafenamide in patients with HIV-1 infection and ongoing substance use disorder: the base study","volume":"10","author":"Havens","year":"2023","journal-title":"Open. Forum Infect. Dis."},{"key":"10.1016\/j.jpba.2026.117724_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cid\/ciy708","article-title":"Tenofovir diphosphate in dried blood spots is strongly associated with viral suppression in individuals with human immunodeficiency virus infections","volume":"68","author":"Castillo-Mancilla","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2026.117724_bib15","unstructured":"Centers for Disease Control and Prevention, TB treatment for persons with HIV. https:\/\/www.cdc.gov\/tb\/topic\/populations\/tbhiv.htm, 2023)."},{"key":"10.1016\/j.jpba.2026.117724_bib16","unstructured":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIVS. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK586306\/, 2025)."},{"key":"10.1016\/j.jpba.2026.117724_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25844","article-title":"Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir\/emtricitabine\/tenofovir alafenamide","volume":"24","author":"Liou","year":"2021","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.jpba.2026.117724_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpba.2011.05.039","article-title":"Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS\/MS detection","volume":"56","author":"Bushman","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117724_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jchromb.2006.05.043","article-title":"Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells","volume":"843","author":"King","year":"2006","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2026.117724_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpba.2018.02.036","article-title":"Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC\u2013MS\/MS","volume":"153","author":"Gautam","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117724_bib21","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/jac\/dkaf186","article-title":"Five-days-on-two-days-off (FOTO) versus daily bictegravir\/emtricitabine\/tenofovir alafenamide in virologically suppressed people with HIV: a pilot randomized clinical trial","volume":"80","author":"Sun","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2026.117724_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jmii.2025.03.002","article-title":"Measurements of tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots of people receiving pre-exposure prophylaxis for HIV with co-formulated tenofovir disoproxil fumarate and emtricitabine","volume":"58","author":"Lin","year":"2025","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.jpba.2026.117724_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2012.747952","article-title":"Update on rifampin, rifabutin, and rifapentine drug interactions","volume":"29","author":"Baciewicz","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jpba.2026.117724_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106362","article-title":"Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs","volume":"181","author":"Deng","year":"2023","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:24:03Z","timestamp":1793309043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526003924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":24,"alternative-id":["S0731708526003924"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117724","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of dried blood spots relative to peripheral blood mononuclear cells for intracellular tenofovir-diphosphate and emtricitabine-triphosphate assessment using liquid chromatography-tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117724"}}